PATENT CLAIM ANALYSIS

Application Number: 16011018
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "217060"]

Abstract:
Compounds of the formula I or II: wherein X, m, Ar, R 1  and R 2  are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.

Claim (Index 15):
The compound of  claim 1 , wherein each R\u2032 is independently: hydrogen; hydroxy; 2-amino-ethyl)-methyl-amino; 2-amino-ethylamino; methy; methoxy; 2-hydroxy-ethyl)-methyl-amino; hydroxymethyl; 2-hydroxy-1-methyl-ethylamino; 2-cyclopropylamino; 2-hydroxy-ethylamino; 2,3-dihydroxy-propylamino; 3-amino-propylamino; aminocarbonyl; 2-hydroxy-ethyl)-isopropyl-amino; bromo; isobutylamino; isopropyl-methyl-amino; 3-hydroxy-propylamino; 1-hydroxymethyl-propylamino; 2-hydroxy-ethyl; 2-acetylamino-ethylamino; 3-hydroxy-propyl; or isopropyl-amino.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 94.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14243074', '10225783', '13546039', '15850720', '14511847']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8022501970310549
- 35 USC 102 Novelty (BERT): 0.5606987872426156
- Combined Prediction Score: 0.7780950560522111
- Mean Citation Score: 340.745314
- Max Citation Score: 462.62836
- Similarity Product: 325.71556704155444

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test